Beryl Drugs shareholders approved the regularisation of Mrs. Neha Sarda as an Independent Director for a 5-year term.
The approval was granted at an Extraordinary General Meeting held on May 11, 2026, concluding the interim appointment.
Mrs. Sarda is a qualified Company Secretary with expertise in corporate law, governance, and compliance matters.
The company confirmed she meets all independence criteria under the Companies Act, 2013 and SEBI LODR Regulations.